🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-02-19
Trial ID
NCT04155710
Treatments Being Tested
This study is to determine the response to acalabrutinib in patients with c...
Status
Completed
Location
Research Site
Start Date
2015-01-12
Trial ID
NCT02337829
Treatments Being Tested
This is a Phase 3, randomized, open-label, multicenter study comparing rocb...
Status
Recruiting
Location
Orchard Healthcare Research
Start Date
2026-04-23
Trial ID
NCT07342478
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of venetoclax monothe...
Status
Completed
Location
Norton Cancer Institute /ID# 149788
Start Date
2016-06-22
Trial ID
NCT02756611
Treatments Being Tested
This study will evaluate the efficacy and safety of venetoclax and obinutuz...
Status
Completed
Location
Medical Center of Aurora
Start Date
2020-05-28
Trial ID
NCT04285567
Treatments Being Tested
The primary objective of this study is to evaluate overall response rate (O...
Status
Terminated
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2014-08-06
Trial ID
NCT02044822
Treatments Being Tested
This research study is evaluating a combination of three drugs called lenal...
Status
Completed
Location
Colorado Blood Cancer Institute
Start Date
2015-12
Trial ID
NCT02441686
Treatments Being Tested
This is a first-in-human Phase 1a/1b multicenter, open-label study designed...
Status
Recruiting
Location
City of Hope
Start Date
2022-04-13
Trial ID
NCT05131022
Treatments Being Tested
The purpose of this study is to determine if Ruxolitinib, an inhibitor of c...
Status
Completed
Location
Sunnybrook Odette Cancer Center
Start Date
2014-04
Trial ID
NCT02015208
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of acalabr...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-02-25
Trial ID
NCT03836261
Treatments Being Tested